12-10909037-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_023920.2(TAS2R13):āc.262A>Gā(p.Ser88Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000411 in 1,461,394 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_023920.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAS2R13 | NM_023920.2 | c.262A>G | p.Ser88Gly | missense_variant | 1/1 | ENST00000390677.2 | NP_076409.1 | |
PRH1 | NM_001291315.2 | c.104-25941A>G | intron_variant | NP_001278244.1 | ||||
PRH1 | NM_001291314.2 | c.-58-24762A>G | intron_variant | NP_001278243.1 | ||||
PRH1-PRR4 | NR_037918.2 | n.545-24762A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS2R13 | ENST00000390677.2 | c.262A>G | p.Ser88Gly | missense_variant | 1/1 | 6 | NM_023920.2 | ENSP00000375095.2 | ||
ENSG00000275778 | ENST00000703543.1 | c.-58-24762A>G | intron_variant | ENSP00000515364.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1461394Hom.: 0 Cov.: 33 AF XY: 0.00000688 AC XY: 5AN XY: 726972
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 03, 2024 | The c.262A>G (p.S88G) alteration is located in exon 1 (coding exon 1) of the TAS2R13 gene. This alteration results from a A to G substitution at nucleotide position 262, causing the serine (S) at amino acid position 88 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.